IDH1 and glioma: Previous studies have indicated that multiparametric MR-based deep learning has diagnostic performance in the differentiation of glioma mimicking encephalitis (Wu et al., 2021), classification of IDH mutation status (Bangalore Yogananda et al., 2020), discrimination of pseudoprogression and true progression (Lee et al., 2020), and determination of molecular subtype in gliomas (Li et al., 2022).